Find the Perfect Plan for Your Investment Journey
S
Latest price
52 Week Range
₩6.40K - ₩19.75K
Next Earnings Date
May 14 2025
Next Earnings Date
May 14 2025
Latest price
Market Cap | ₩412.84B |
EV | ₩412.25B |
Shares Outstanding | 51.26M |
Beta | 2.10 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 5.30% |
EPS | -9.90% |
Operating Cash Flow | 40.30% |
Free Cash Flow | 58.20% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -5.85% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
Shinpoong Pharmaceutical Co.,Ltd
A019170
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ryu, Jei-Man
Employees
815
Website
shinpoong.co.krIPO Date
2000-01-04
Headquarters
161, Yeoksam-ro, Gangnam-gu, Seoul 06246, South Korea
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved